// App-Quantinova.ai

TPS2112 : Multidose oxygen therapeutic for radiation sensitization treatment of glioblastoma multiforme.

Researchers

Presenter

  • David Brown Wilson

Principal Investigators

  • Jason Lickliter

  • Evan Unger

  • Olivia Longacre

Medical Centers

  • NuvOx Pharma, Tucson, AZ

  • Nucleus Network Limited, Melbourne, AustraliaNuvOx Pharma, Tucson, AZ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved